These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9142464)

  • 1. Clinical pharmacokinetics and therapeutic efficacy of ceftriaxone in Chinese adults.
    Zhu Z; Wang AX; Li Y
    Chemotherapy; 1997; 43(3):218-26. PubMed ID: 9142464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients.
    Joynt GM; Lipman J; Gomersall CD; Young RJ; Wong EL; Gin T
    J Antimicrob Chemother; 2001 Apr; 47(4):421-9. PubMed ID: 11266414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamic target attainment of ceftriaxone in adult severely ill sub-Saharan African patients: a population pharmacokinetic modelling study.
    Bos JC; Prins JM; Mistício MC; Nunguiane G; Lang CN; Beirão JC; Mathôt RAA; van Hest RM
    J Antimicrob Chemother; 2018 Jun; 73(6):1620-1629. PubMed ID: 29522167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of ceftriaxone and pharmacodynamic considerations in haemodialysed patients.
    Simon N; Dussol B; Sampol E; Purgus R; Brunet P; Lacarelle B; Berland Y; Bruguerolle B; Urien S
    Clin Pharmacokinet; 2006; 45(5):493-501. PubMed ID: 16640454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preincisional single-dose ceftriaxone for the prophylaxis of surgical wound infection.
    Chalkiadakis GE; Gonnianakis C; Tsatsakis A; Tsakalof A; Michalodimitrakis M
    Am J Surg; 1995 Oct; 170(4):353-5. PubMed ID: 7573727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative analysis of pharmacokinetics of ceftriaxone in serum and pleural fluid in humans: a study of once daily administration by intramuscular and intravenous routes.
    Goonetilleke AK; Dev D; Aziz I; Hughes C; Smith MJ; Basran GS
    J Antimicrob Chemother; 1996 Dec; 38(6):969-76. PubMed ID: 9023644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of ceftriaxone in intensive care].
    Bouget J; Garré M; Reyman JM; Guedes Y; Cartier F
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):706-10. PubMed ID: 3054752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of plasma and free tissue levels of ceftriaxone in rats by microdialysis.
    Kovar A; Dalla Costa T; Derendorf H
    J Pharm Sci; 1997 Jan; 86(1):52-6. PubMed ID: 9002459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone is an efficient component of antimicrobial regimens in the prevention and initial management of infections in end-stage renal disease.
    Trimarchi H; Lafuente P; Suki WN
    Am J Nephrol; 2000; 20(5):391-5. PubMed ID: 11092997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioavailability of cefquinome and ceftriaxone in premature calves.
    Corum O; Yildiz R; Ider M; Altan F; Ok M; Uney K
    J Vet Pharmacol Ther; 2019 Nov; 42(6):632-639. PubMed ID: 31197850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose pharmacokinetics of ceftriaxone in patients with end-stage renal disease and hemodialysis.
    Losno Garcia R; Santivañez V; Battilana CA
    Chemotherapy; 1988; 34(4):261-6. PubMed ID: 3208543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: review.
    Bijie H; Kulpradist S; Manalaysay M; Soebandrio A
    J Chemother; 2005 Feb; 17(1):3-24. PubMed ID: 15828439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of the effects of four cephalosporins against Escherichia coli in vitro and in vivo.
    van Ogtrop ML; Mattie H; Guiot HF; van Strijen E; Hazekamp-van Dokkum AM; van Furth R
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1932-7. PubMed ID: 2291658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients.
    Schleibinger M; Steinbach CL; Töpper C; Kratzer A; Liebchen U; Kees F; Salzberger B; Kees MG
    Br J Clin Pharmacol; 2015 Sep; 80(3):525-33. PubMed ID: 25808018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Level of evidence for therapeutic drug monitoring of ceftriaxone].
    Dailly E; Verdier MC; Deslandes G; Bouquié R; Tribut O; Bentué-Ferrer D
    Therapie; 2012; 67(2):145-9. PubMed ID: 22850101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of ceftriaxone: a pharmacokinetic-pharmacodynamic perspective on the impact of minimum inhibitory concentration and serum protein binding.
    Perry TR; Schentag JJ
    Clin Pharmacokinet; 2001; 40(9):685-94. PubMed ID: 11605716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ceftriaxone in patients undergoing continuous veno-venous hemofiltration.
    Kroh UF; Lennartz H; Edwards DJ; Stoeckel K
    J Clin Pharmacol; 1996 Dec; 36(12):1114-9. PubMed ID: 9013367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ceftriaxone administered by the intravenous, intramuscular or subcutaneous routes to dogs.
    Rebuelto M; Albarellos G; Ambros L; Kreil V; Montoya L; Bonafine R; Otero P; Hallu R
    J Vet Pharmacol Ther; 2002 Feb; 25(1):73-6. PubMed ID: 11874531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the probability of target attainment between ceftriaxone and cefepime in the cerebrospinal fluid and serum against Streptococcus pneumoniae.
    Lodise TP; Nau R; Kinzig M; Jones RN; Drusano GL; Sörgel F
    Diagn Microbiol Infect Dis; 2007 Aug; 58(4):445-52. PubMed ID: 17512154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftriaxone pharmacokinetics during iatrogenic hydroxyethyl starch-induced hypoalbuminemia: a model to explore the effects of decreased protein binding capacity on highly bound drugs.
    Mimoz O; Soreda S; Padoin C; Tod M; Petitjean O; Benhamou D
    Anesthesiology; 2000 Sep; 93(3):735-43. PubMed ID: 10969307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.